Drugs / Na-APR-1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02476773 | Jan 2016 → Jun 2017 | hookworm infectious disease | Baylor College of Medicine | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Na-APR-1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02476773 ↗ |
| Known as | M74 | “Na-APR-1 (M74)/Alhydrogel” NCT02476773 ↗ |
| Modality | Protein / enzyme biologic | “Na-GST-1 and Na-APR-1 are proteins expressed during the adult stage of the Necator americanus hookworm life cycle” NCT02476773 ↗ |